GEA Pharma & Healthcare Insight stories
Insight stories
.jpg?h=1350&iar=0&w=2400&rev=1b429cc0c71d46d499711e0731d4a0cd&hash=BB51B496350FA3FA7A4E892151983C5E&mw=3840 "biopharma industry")
Perfüzyon separatörleri biyofarma proseslerini hızlandırıyor
Küçük biyofarma üretim işletmeleri genellikle yenilikçi tıbbi tedavilerin yaygınlaşmasının arkasındaki itici güçtür. GEA, verimliliği optimize edilmiş devamlı işleme sağlayan perfüzyon separatörleri ile bu üreticilerin hücre hasat kapasitelerinde devrim yapıyor. İlk kez uygun disk kümeli separatörler, kompakt, tek-kullanımlı makinelere dönüştürülerek alandan, iş gücünden ve çabadan tasarruf sağlıyor ve aynı zamanda daha yüksek üretim çıktısı ve hızına kapı açıyor.
Continuous Innovation: How GEA is Leading the Future of Pharmaceutical Manufacturing
From the first ConsiGma® line in 2004 to the launch of CDC Flex today, GEA has been at the forefront of pharmaceutical innovation.
Continuous innovation is our commitment — to our customers, to the industry, and to a better world.
Innovating patient care with aseptic spray drying
At GEA, our commitment to engineering for a better world fuels our pursuit of innovative solutions that enhance patient care and safety. One of our most promising ventures in recent years is aseptic spray drying – a technology that promises to revolutionize pharmaceutical manufacturing.
Aşı üretim teknolojisi, hayvan hastalıkları kontrolünde hayati bir öneme sahip
Evcil hayvan hastalıkları çoğunlukla yerel ve global ekonomiler üzerinde önemli etkilere sahip olmakla birlikte aynı zamanda kamu sağlığı için potansiyel bir tehdit oluşturmaktadır. Aşılar, evcil hayvan hastalıklarının aktarılması ile savaşta güçlü bir araç görevi yapmaktadır, ancak kalite önemlidir. Bizleri hastalıksız bir dünyaya daha da yaklaştırma çabalarına yardımcı olmak için GEA, bu yüksek kaliteli aşıların komple üretim prosesine yardımcı ekipmanlar sağlamaktadır.
How continuous manufacturing is redefining the pharmaceutical supply chain
Continuous pharmaceutical manufacturing is no longer a niche trend. It’s already happening. Although implementation and knowledge transfer can be time consuming, early adopters are embarking on a new trajectory of business excellence, benefiting from numerous competitive advantages and staying ahead of the market.
Development of new vaccines
GEA, the globally active mechanical and plant engineering company, takes its role in the fight against the coronavirus — and any other — epidemic, extremely seriously. But how do we prove that a vaccine against the virus works: is it safe for children, the elderly and/or pregnant women? It will no doubt take some time to produce 7 billion doses, which is something that cannot be done overnight; but, first, we need to be sure that it works safely … for everyone!
The unsung heroes of global health and well-being
When we consider the concept of health, we generally think about being free from injury or illness. We might look at a person’s mental or physical condition, or delve more deeply into nutrition, exercise, sleep and the environment we live in. In recent times, vaccines and medicines have taken center stage as the world battles the ongoing pandemic. Yet, often behind the scenes and anonymous, a vast array of technologies and innovations are working hard, every day, to ensure that the food, drugs, water and energy that we use to stay well are safe, reliable and sustainable. At the heart of many of those processes – and supporting healthy living – is GEA equipment.
